サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566894

レジオネラ菌検査キット市場：タイプ別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Legionella Testing Kits Market By Type , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
レジオネラ菌検査キット市場：タイプ別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レジオネラ菌検査キット市場

レジオネラ菌検査キット市場は、2023年に3億2,400万米ドルと評価され、2024年から2033年にかけてCAGR 7.7%で成長し、2033年には6億8,450万米ドルに達すると予測されています。

レジオネラ菌検査キットは、レジオネラ菌の検出を可能にする迅速なDIYテスターです。このキットは基本的に、介護施設や病院、接客業、プールや噴水、冷却塔などの空間で使用されます。検査は、培養法、ポリメラーゼ連鎖反応法、免疫学的アッセイなど、多様な生体分子プロセスを用いて行われます。キットの主な特長は、短納期、高精度、使いやすさなどです。

水を媒介とする感染症の予防に対する意識の高まりは、レジオネラ菌検査キット市場の主要な促進要因です。商業施設や公共施設では、公共の安全に関する規制が強化されており、検査キットの採用を後押ししています。また、技術の進歩が検査キットの有効性と信頼性を高め、市場開拓を後押ししています。最近では、検査結果の迅速な提供やデジタル・ソリューションとの統合が顕著な動向となっています。検査結果のシームレスな分析と報告を容易にするため、メーカー各社はデジタル・データ管理システムと統合可能なキットを設計しています。この統合は、水質と安全性のパターンを追跡し、効果的な意思決定を行うのに役立ちます。

しかし、高精度で精度の高い上級バージョンのキットのコストは依然としてかなり高く、小規模な組織では購入が制限されています。さらに、サンプルの採取とキットの取り扱いは複雑なプロセスであり、訓練と実践が必要です。キットのわずかな汚染が信頼性に影響し、市場の成長を妨げます。反対に、公共の場所や建物で定期的な水質検査を実施する政府の取り組みは、市場に有利な機会をもたらしています。例えば、米国では、2024年1月に連邦政府の複数の建物で水質検査を実施し、建物を訪れたり、建物で働いたりする人々の健康を確保しています。

セグメント別レビュー

レジオネラ菌検査キット市場は、タイプ、エンドユーザー、地域に区分されます。タイプ別では、市場は培養液、尿中抗原検査、ポリメラーゼ連鎖反応、血清学、直接蛍光抗体検査に分けられます。エンドユーザー別では、病院・診療所、臨床検査室、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

タイプ別では、ポリメラーゼ連鎖反応セグメントが2023年に最大シェアを占めました。

エンドユーザー別では、病院・クリニックセグメントが2023年に市場で高いシェアを獲得しました。

地域別では、北米が2023年に最も高い収益を上げました。

本レポートで可能なカスタマイズ（追加費用とスケジュールがあります。）

  • 顧客の関心に応じた企業プロファイルの追加

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 レジオネラ菌検査キット市場：タイプ別

  • 市場概要
  • 培養培地
  • 尿中抗原検査
  • ポリメラーゼ連鎖反応
  • 血清検査
  • 直接蛍光抗体検査

第5章 レジオネラ菌検査キット市場：エンドユーザー別

  • 市場概要
  • 病院および診療所
  • 臨床検査室
  • その他

第6章 レジオネラ菌検査キット市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国のレジオネラ菌検査キット市場
    • カナダのレジオネラ菌検査キット市場
    • メキシコのレジオネラ菌検査キット市場
  • 欧州
    • 主要市場動向と機会
    • フランスのレジオネラ菌検査キット市場
    • ドイツのレジオネラ属菌検査キット市場
    • イタリアのレジオネラ属菌検査キット市場
    • スペインのレジオネラ属菌検査キット市場
    • 英国のレジオネラ菌検査キット市場
    • その他欧州のレジオネラ菌検査キット市場
  • アジア太平洋
    • 主要市場動向と機会
    • 中国のレジオネラ属菌検査キット市場
    • 日本のレジオネラ属菌検査キット市場
    • インドのレジオネラ属菌検査キット市場
    • 韓国のレジオネラ菌検査キット市場
    • オーストラリアのレジオネラ菌検査キット市場
    • その他アジア太平洋のレジオネラ菌検査キット市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルのレジオネラ属菌検査キット市場
    • 南アフリカのレジオネラ属菌検査キット市場
    • サウジアラビアのレジオネラ属菌検査キット市場
    • その他のラテンアメリカ・中東・アフリカのレジオネラ属菌検査キット市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific
  • Merck Group KGaA
  • Pall Corporation
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Hygiena
  • Veolia Water Technologies
  • Pro-Lab Diagnostics
  • Phigenics, LLC
目次
Product Code: A264537

Legionella Testing Kits Market

The legionella testing kits market was valued at $324.0 million in 2023 and is projected to reach $684.5 million by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

A legionella testing kit is a rapid do-it-yourself tester which enables detection of the bacteria Legionella. This kit is essentially used in spaces such as care homes & hospitals, hospitality, pools & fountains, and cooling towers. The testing is performed using diverse biomolecular processes such as culture method, polymerase chain reaction technique, or immunological assay. The key attributes of the kit include short turnaround time, high precision, and ease of usage.

Increase in awareness about the prevention of water borne diseases is a key driver of the legionella testing kits market. Commercial and public buildings have strengthened their regulations regarding public safety, boosting the adoption of testing kits. In addition, advancements in technology have enhanced the efficacy and reliability of the kits, thereby augmenting the development of the market. In recent times, quick delivery of results and integration of the kits with digital solutions are the prominent trends acquiring traction. To facilitate seamless analysis and reporting of test results, manufacturers are designing kits with the ability to be assimilated with digital data management systems. This integration assists in tracking the patterns of water quality & safety and making effective decisions.

However, the cost of advanced version of kits with high precision and accuracy remains significantly high, restricting small organizations from purchasing them. Furthermore, the collection and handling of the sample & kit is a complex process which requires training & practice. Slight contamination of the kit impacts its reliability, thereby hampering the growth of the market. Contrarily, efforts by governments to conduct periodic water testing in public places and buildings are presenting lucrative opportunities for the market. For instance, the U.S. General Service Administration conducted water testing across several federal buildings in January 2024 to ensure the wellness of individuals visiting and working in the buildings.

Segment Review

The legionella testing kits market is segmented into type, end user, and region. On the basis of type, the market is divided into culture media, urine antigen testing, polymerase chain reaction, serology, and direct fluorescent antibody test. Depending on end user, it is classified into hospitals & clinics, clinical laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the polymerase chain reaction segment accounted for the largest share in 2023.

Depending on end user, the hospitals & clinics segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global legionella testing kits market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Merck Group KGaA, Pall Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Hygiena, Veolia Water Technologies, Pro-Lab Diagnostics, and phigenics, llc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Culture Media
  • Urine Antigen Testing
  • Polymerase Chain Reaction
  • Serology
  • Direct Fluorescent Antibody Test

By End User

  • Hospitals and Clinics
  • Clinical Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck Group KGaA
    • Pall Corporation
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories
    • Hygiena
    • Veolia Water Technologies
    • Pro-Lab Diagnostics
    • Phigenics, LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: LEGIONELLA TESTING KITS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Culture Media
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Urine Antigen Testing
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Polymerase Chain Reaction
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Serology
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Direct Fluorescent Antibody Test
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: LEGIONELLA TESTING KITS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinical Laboratories
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: LEGIONELLA TESTING KITS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Legionella Testing Kits Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Legionella Testing Kits Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Legionella Testing Kits Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Legionella Testing Kits Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Legionella Testing Kits Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Legionella Testing Kits Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Legionella Testing Kits Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Legionella Testing Kits Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Legionella Testing Kits Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Legionella Testing Kits Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Legionella Testing Kits Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Legionella Testing Kits Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Legionella Testing Kits Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Legionella Testing Kits Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Legionella Testing Kits Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Legionella Testing Kits Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Legionella Testing Kits Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Legionella Testing Kits Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Legionella Testing Kits Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. IDEXX Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Thermo Fisher Scientific
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Merck Group KGaA
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Pall Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Bio-Rad Laboratories, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Abbott Laboratories
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Hygiena
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Veolia Water Technologies
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Pro-Lab Diagnostics
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Phigenics, LLC
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments